CTOs on the Move

MedicaMetrix

www.medicametrix.com

 
We are a startup up medical device company whose sole focus and mission are to transform patient care through innovative Med-tech solutions. Our initial product is a minimally invasive Prostate Volume Measurement Device to help doctors evaluate a patient`s prostate health. Our solution includes a controller that receives measurement data from an encoder device. The encoder a disposable, single-use component made with an injection molding process. We are in the proof of concept phase and want to move to test marketing trials and production by end of 2020.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Snowden-Pencer Inc

Snowden Pencer was founded by Leonard Snowden and George Pencer, both specially trained instrument craftsmen who pioneered important technology in the manufacturing of surgical instruments. This technology used tungsten carbide in the working end of an

Three Rivers Orthopedic

Three Rivers Orthopedic is a Latrobe, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamason

Metamason is dedicated to improving healthcare through technological innovation. Our health-focused software platform uses 3D scans of the body to create individually customized, 3D-printed products engineered for flawless fit.

Sunrise Community Health Center

Sunrise Community Health Center is a Greeley, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuromod Devices

Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as ringing in the ears​.